Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

nanotype GmbH

www.nanotype.de

Latest From nanotype GmbH

Shrinking Discovery

The theory that smaller is better--as it is has been in the computer industry--is now driving enthusiasm for nanotechnology, a term that refers to the process of manipulating materials at atomic scale. New players are crowding under this hot rubric, including many working at not nearly so small a scale. Drug discovery methods are among the most compelling near-term nano-applications, but start-ups face challenges like those met by micro-scale pioneers Affymetrix and Caliper. Firms must show they can physically create systems they describe, and that teeny discovery methods actually matter for bench scientists. Business models in this emerging sector reflect the difficulties of harnessing novel science in ways that will satisfy drugmakers who've become extra-tough customers under pressure to deliver commercial results in a shifting, financially depressed market. Some start-ups are working on a fee-for-service basis, on specific projects that address customers' immediate needs. Others are deliberately doing development work on their own, gathering data to attract partnerships that may prove all the more rewarding because of their measured starts.
BioPharmaceutical Strategy

Start-Up Previews (3/02)

A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group, G-Protein Coupled Receptors, features profiles of Aptus Genomics Inc., Axovan Ltd., Norak Biosciences Inc. and 7TM Pharma. Plus these Selected Start-Ups across Health Care: ALung Technologies Inc., CancerVax Corp., MedExact Inc. and nanotype GMBH.

Nanotype GMBH

Nanotype GMBH has developed an assay system based on molecular force comparison, which measures the forces required to disrupt intermolecular bonds. The basic technology has potential applications in many industries, but the company will initially focus on health care, including drug discovery, genomics, proteomics and pharmacogenomics.
BioPharmaceutical Platform Technologies
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
      • Genomics-Proteomics
  • In Vitro Diagnostics
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Germany
  • Parent & Subsidiaries
  • nanotype GmbH
  • Senior Management
  • Gunnar Brink, CEO
  • Contact Info
  • nanotype GmbH
    Phone: (49) 89 89 87 89 0
    Lochhamer Schlag 12, Schellingstr. 4,
    Gräfelfing, D-82166
    Germany
Advertisement
Advertisement
UsernamePublicRestriction

Register